Summary of Consolidated Financial Statements for the Year Ended December 31, 2013 [Japanese Standard] February 10, 2014 Company name: Lion Corporation Listed stock exchanges: Tokyo Stock Exchange Code: 4912 URL: http://www.lion.co.jp/ Representative: Itsuo Hama, Representative Director and President Contact: Yoshiaki Kamao, Director of Finance Department Telephone: +81-3-3621-6211 Annual meeting of shareholders: March 28, 2014 (plan) Start date for payment of year end dividend: March 5, 2014 (plan) Scheduled date of filing of financial report: March 31, 2014 (plan) Supplementary materials prepared for quarterly results: Yes Quarterly results information meeting held: Yes (for investors and analysts, etc.) Figures in this and subsequent tables are rounded down to the nearest million. 1. Consolidated Results for the Year Ended December 31, 2013 (January 1, 2013 – December 31, 2013) (1)Consolidated Results (cumulative total) (Percentage figures denote year-on-year change) Net sales Operating income Ordinary income Net income Millions of yen % Millions of yen % Millions of yen % Millions of yen % Fiscal 2013 352,005 5.0 10,819 50.0 12,300 43.6 6,097 44.0 Fiscal 2012 335,171 2.3 7,213 (35.4) 8,564 (29.7) 4,235 3.9 Note: Comprehensive income: December 31, 2013: ¥13,261 million (15.5%) December 31, 2012: ¥11,478 million (347.5%) EPS Diluted EPS Return on equity Ratio of ordinary income to total assets Ratio of operating income to net sales Yen Yen % % % Fiscal 2013 22.72 22.68 5.4 4.6 3.1 Fiscal 2012 15.77 15.75 4.0 3.4 2.2 Note: Equity in earnings of non-consolidated subsidiaries and affiliates: ¥696 million in FY 2013 and ¥803 million in FY 2012. (2)Consolidated Financial Position Total assets Net assets Shareholders’ equity to total assets Net assets per share Millions of yen Millions of yen % Yen Fiscal 2013 282,098 124,232 42.0 441.59 Fiscal 2012 257,595 114,163 42.4 407.08 Note: Shareholders’ equity: December 31, 2013: ¥118,448 million December 31, 2012: ¥109,261 million
35
Embed
Summary of Consolidated Financial Statements for ... - Lion
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Summary of Consolidated Financial Statements for the Year Ended
December 31, 2013 [Japanese Standard]
February 10, 2014
Company name: Lion Corporation Listed stock exchanges: Tokyo Stock Exchange Code: 4912 URL: http://www.lion.co.jp/ Representative: Itsuo Hama, Representative Director and President Contact: Yoshiaki Kamao, Director of Finance Department Telephone: +81-3-3621-6211 Annual meeting of shareholders: March 28, 2014 (plan) Start date for payment of year end dividend: March 5, 2014 (plan) Scheduled date of filing of financial report: March 31, 2014 (plan) Supplementary materials prepared for quarterly results: Yes Quarterly results information meeting held: Yes (for investors and analysts, etc.) Figures in this and subsequent tables are rounded down to the nearest million.
1. Consolidated Results for the Year Ended December 31, 2013
In toothpaste, sales of Lion’s mainstay brand Dentor Systema were firm, and those of the
new-and-improved Hitect Shoyaku no Megumi (Bountiful Herbal Medicine) were steady. However,
due in part to sluggish sales of Dentor Clear MAX, overall sales were less than those in the previous
fiscal year.
In toothbrushes, sales of Clinica Advantage toothbrushes, featuring an extremely thin head and
slender neck to clean right to the back of the molars, garnered favorable consumer reviews, and
overall sales edged up compared with the same period of the previous fiscal year.
In mouthwashes, sales of Dentor Systema dental rinses were firm, but sales of platius beautiful
teeth essence dental rinse were sluggish, resulting in overall sales that were down from those in the
same period of the previous fiscal year.
Beauty Care Products
In hand soaps, while sales of KireiKirei Medicated Foaming Hand Soap were strong, sales of regular liquid hand soaps were stagnant. As a result, overall sales remained level with those in the previous fiscal year. In antiperspirants and deodorants, new Ban Shower Deodorant, an aqueous mist spray deodorant that provides a long-lasting feeling of smooth skin thanks to proprietary micro powder ingredients, garnered favorable consumer reviews. However, sluggish sales of Lion’s mainstay Ban Deodorant Powder Spray line resulted in overall sales that were lower than those in the same period of the previous fiscal year.
Fabric Care Products
In laundry detergents, sales of super-concentrated TOP HYGIA, which enhances the antibacterial properties of laundry through washing, and TOP Clear Liquid were favorable as the market for liquid laundry detergents continued to expand. However, powder detergents were affected by market shrinkage, and overall sales were below those of the previous year. In fabric softeners, the Kaori to Deodorant no SOFLAN (SOFLAN with Fragrance and Deodorant) Aroma Rich series enjoyed strong sales and the new-and-improved Kaori to Deodorant no SOFLAN (SOFLAN with Fragrance and Deodorant) Aroma Natural series received favorable consumer reviews. As a result, overall sales were substantially greater than those in the same period of the previous fiscal year. Additionally, newly released TOP HYGIA Fabric Refresher antibacterial, antiviral deodorant, a new product that eliminates bacteria, viruses and odors with just a quick spray, garnered favorable consumer reviews.
Lion Corporation (Code 4912): Consolidated Financial Statements for the Year Ended December 31, 2013
5
Living Care Products
In dishwashing detergents, although sales of the CHARMY Crysta series for dishwashers were strong, those of the CHARMY Awa no Chikara (Power of Suds) series were weak, leading to an overall year-on-year sales decline. In household cleaners, sales of bathroom fungicide LOOK Bath Antimold Fogger were favorable and new LOOK Mame-Pika Antibacterial Toilet Cleaner, containing antibacterial ingredients that fight odor-causing bacteria, garnered favorable customer reviews. As a result, overall sales were higher than those of the previous fiscal year.
Pharmaceutical Products
In analgesics, sales of Lion’s mainstay brand BUFFERIN A were affected by intensifying competition, and overall sales fell year on year. In eye drops, Smile 40 Premium, a new, effective ophthalmic remedy that helps alleviate tired, bleary eyes caused by aging and overuse, as well as Smile 40EX GOLD Mild, featuring a milder cooling sensation for gentle, comfortable application, both received favorable consumer reviews. As a result, overall sales increased substantially compared with the corresponding period of the previous fiscal year. In insecticides, sales of Lion’s mainstay Varsan fogger series were affected by market contraction, and overall sales fell year on year.
Other Products
In direct-to-consumer sales products, within functional food products, sales of Lion’s mainstay brand Nice rim essence Lactoferrin were strong, and new Fleuria, a hair care series for the mature woman that promotes healthy and beautiful hair, received favorable consumer reviews. As a result, overall sales were considerably higher than in the corresponding period of the previous fiscal year. In pet supplies, sales of Nioi wo Toru Suna (Deodorizing Cat Litter) were firm, but overall sales remained level with those in the corresponding period of the previous fiscal year.
<Industrial Products Business>
The Industrial Products Business segment engages in the manufacture and sale of activators derived from oils and fats, electro-conductive carbon, detergents for institutional use and other products. Segment net sales increased 3.7% compared with the corresponding period of the previous fiscal year. Segment income, however, increased 115.8% year on year due in part to extended sales of highly profitable products.
(Millions of yen)
FY2013 Ratio to net sales
FY2012 Ratio to net sales
Increase/ decrease
Change
Net sales 51,630 49,784 1,846 3.7%
Segment income 778 1.5% 360 0.7% 417 115.8%
Note: Net sales include internal net sales within and among segments, which amounted to ¥20,394 million in FY2013 and
¥19,625 million in FY2012
In activators derived from fats and oils, sales of raw materials for detergents and shampoos were strong, and overall sales edged up year on year. In electro-conductive carbon, overseas sales of products used in electronics devices were firm, and overall sales increased considerably year on year. In detergents for institutional use, sales of hand soaps and alcohol sanitizers for kitchen use were strong, leading to overall sales that were considerably higher than those in the same period of the
Lion Corporation (Code 4912): Consolidated Financial Statements for the Year Ended December 31, 2013
6
previous fiscal year.
<Overseas Business>
The Overseas Business segment comprises business operations primarily in Thailand, South Korea
and China, with operations newly begun in the Philippines. Segment net sales increased 29.9%
year on year (or in terms of real net sales, which exclude the influence of exchange rate
conversions, increased 5.2%). Segment income decreased 1.9% due to increases in competition
costs made in order to strengthen market position.
(Millions of yen)
FY2013 Ratio to
net sales FY2012
Ratio to
net sales
Increase/
decrease Change
Net sales 76,865 59,173 17,691 29.9%
Segment income 1,435 1.9% 1,462 2.5% (27) (1.9%)
Note: Net sales include internal net sales within and among segments, which amounted to ¥4,208 million in FY2013 and
¥3,079 million in FY2012.
In Thailand, sales of Systema toothbrushes were strong and those of laundry detergents were steady. As a result, overall sales rose considerably compared with the previous fiscal year. Overall sales after yen conversions also rose significantly. In South Korea, sales of dishwashing detergents were stagnant, but sales of KireiKirei hand soap and Beat brand liquid laundry detergent were strong. As a result, overall sales increased only slightly compared with the previous fiscal year, although overall sales after yen conversions rose significantly. In China, sales of Systema toothbrushes were strong, leading to a slight year-on-year increase in overall sales. Overall sales after yen conversions were substantially increased.
<Other>
(Millions of yen)
FY2013 Ratio to
net sales FY2012
Ratio to
net sales
Increase/
decrease Change
Net sales 28,723 29,798 (1,075) (3.6%)
Segment income 1,016 3.5% 971 3.3% 44 4.6%
Note: Net sales include internal net sales within and among segments, which amounted to ¥23,318 million FY2013 and
¥25,164 million FY2012.
In Other, which includes the construction contracting business, overall sales came to ¥28,723 million, a year-on-year decrease of 3.6%. Segment income came to ¥1,016 million, up 4.6% from the previous fiscal year. (2) Qualitative Information Concerning the Forecast of Consolidated Financial Results <Consolidated> (Millions of yen)
FY 2014 forecast FY 2013 Increase/decrease Change
Net sales 360,000 352,005 7,994 2.3%
Operating income 12,000 10,819 1,180 10.9%
Ordinary income 13,000 12,300 699 5.7%
Net income 7,000 6,097 902 14.8%
EPS (yen) 26.10 22.72 3.37 14.8%
During fiscal 2014, although continued recovery is forecast for the Japanese economy, concerns remain
Lion Corporation (Code 4912): Consolidated Financial Statements for the Year Ended December 31, 2013
7
due to a temporary drop expected in domestic demand, which is driven primarily by personal consumption, accompanying the coming increase in the consumption tax rate. The economic outlook for the global economy is expected to remain unclear due to such factors as trends in U.S. monetary policy and economic deceleration in emerging countries. The business environment of the domestic toiletries industry, the Lion Group’s main business domain, is expected to grow more challenging, reflecting the impact of the consumption tax rate increase, intensifying competition in stores and rises in materials costs. Amid these circumstances, the Lion Group will continue to steadily advance strategies based on the “Vision 2020 Part-1 (V-1 Plan).” In the Consumer Products Business segment, the Lion Group will release new, high-value-added products in its mainstay toothpaste, antiperspirant and deodorant and analgesics brand lines to reinforce its profit base. The Group will also work to expand its direct-to-consumer sales product business through aggressive marketing activity, particularly of hair care products released in fiscal 2013 that target mature women. As a result of these initiatives, the Lion Group expects overall sales to increase in this business segment. In the Industrial Products Business segment, the Lion Group will focus on cultivating new customers for its detergents for institutional use while strengthening market development in such key product areas as electro-conductive carbon and other highly functional products as well as activators derived from oils and fats. Sales in this business segment, however, are expected to be lower in fiscal 2014, reflecting the reorganization of segment businesses with priority on profitability. With regard to the Overseas Business segment, the Lion Group will bolster its marketing activities, primarily in the areas of oral care products and laundry detergents. In addition, the Group is aiming for business expansion in the Philippines, where it began operations in fiscal 2013, and in the MES (methyl ester sulfonate) business in Malaysia, where it recently increased its production capacity. Based on these efforts, the Group expects overall sales in this business segment to rise. As a result of the above, consolidated results forecasts for fiscal 2014 are as follows: net sales of ¥360,000 million (up 2.3% year on year), operating income of ¥12,000 million (up 10.9% year on year), ordinary income of ¥13,000 million (up 5.7% year on year) and net income of ¥7,000 million (up 14.8% year on year). (Preconditions for the Estimated Figures in Outlook for Fiscal 2014) Lion adopted the following foreign exchange rates in the calculation of the aforementioned estimated figures: ¥102 = US$1.00 ¥3.1 = 1.00 baht
Lion Corporation (Code 4912): Consolidated Financial Statements for the Year Ended December 31, 2013
8
2. Qualitative Information Concerning Consolidated Financial Status
(1) Status of Assets, Liabilities, Net Assets
<Consolidated Financial Status >
FY 2013 FY 2012
Increase/
decrease
Total assets (millions of yen) 282,098 257,595 24,502
Net assets (millions of yen) 124,232 114,163 10,069
Shareholders’ equity to total assets *1 (%) 42.0 42.4 (0.4)
Net assets per share *2 (yen) 441.59 407.08 34.51
*1 Shareholders’ equity to total assets = (Net assets – Subscription rights to shares and Minority interests) / Total assets
*2 Subscription rights and minority interests were excluded from calculation of net assets per share.
Total assets rose ¥24,502 million compared with the previous consolidated fiscal year-end to
¥282,098 million. This is primarily attributable to an increase in marketable securities. Net assets
increased ¥10,069 million to ¥124,232 million. Shareholders’ equity to total assets stood at 42.0%.
(2) Status of Cash Flows
<Consolidated Cash Flows> (Millions of yen)
FY 2013 FY 2012 Increase/
decrease
Net cash provided by (used in) operating activities 22,910 18,762 4,147
Net cash provided by (used in) investment activities (12,819) (9,172) (3,647)
Net cash provided by (used in) financing activities (2,772) (4,923) 2,151
Effect of exchange rate change on cash and cash equivalents 709 602 106
Net increase (decrease) in cash and cash equivalents 8,027 5,273 2,754
Cash and cash equivalents at end of period 48,941 40,913 8,027
Net cash provided by operating activities totaled ¥22,910 million, due mainly to a decrease in notes
and accounts receivable—trade.
Net cash used in investing activities totaled ¥12,819 million, due in part to the purchase of property,
plant and equipment.
Net cash used in financing activities totaled ¥2,772 million. Major components of this reduction in
cash flows included cash dividends paid and repayments of long-term loans payable.
As a result of the above, cash and cash equivalents as of December 31, 2013 increased ¥8,027
million to ¥48,941 million compared with the consolidated fiscal year ended December 31, 2012.
(3) Forecast of Fiscal 2014 Consolidated Cash Flows
In cash flows from operating activities, Lion projects income before income taxes of approximately
¥12,500 million. Lion estimates depreciation and amortization changes of about ¥11,000 million.
In cash flows from investment activities, Lion plans to undertake capital expenditures of around
¥11,000 million during fiscal 2014.
The cash flows from financing activities are expected to decrease to about ¥25,500 million mainly
Lion Corporation (Code 4912): Consolidated Financial Statements for the Year Ended December 31, 2013
9
due to cash dividends paid and the repayment of loans payable.
Based on these projections, Lion estimates that cash and cash equivalents at the end of fiscal
2014 will decrease approximately ¥13,000 million year on year.
(4) Changes in cash flow indicators
FY 2009 FY 2010 FY 2011 FY 2012 FY 2013
Shareholders’ equity to total assets (%) 39.2 39.3 40.9 42.4 42.0
Shareholders’ equity to total assets on a
market value basis (%) 47.8 45.6 49.0 45.7 55.8
Debt redemption (years) 1.9 1.8 3.2 1.8 1.6
Interest coverage ratio 23.2 30.0 12.5 27.6 32.2
(Notes)
Shareholders’ equity to total assets: Net assets / Total assets
Shareholders’ equity to total assets on a market value basis: Value of shares / Total assets
* All the indicators are based on consolidated financial data.
* “Value of shares” is calculated on the basis of the “closing stock price as of the end of the term” multiplied by “the number
of outstanding stocks as of the end of the term” (after the deduction of treasury stocks).
* “Cash flows from operating activities” are those in the consolidated cash flow data.
“Interest-bearing liabilities” means all liabilities that are bearing interest among the liabilities in the consolidated
balance sheet. For the amount of interest paid, figures in the consolidated cash flow data are used.
3. Basic Policy on the Distribution of Earnings and Cash Dividends
Lion considers its most important management issue to be the return of profits to shareholders on a
permanent and stable basis. To this end, the Company strives to consistently lift consolidated
earnings capacity in an effort to ensure the payment of continuous and stable cash dividends.
Taking into consideration the appropriate level of internal reserves required to secure medium- and
long-term growth, Lion also undertakes the acquisition of treasury stock. Working to reinforce the
Company’s growth potential and to develop a sustainable business foundation, Lion allocates
internal reserves to research and development, capital investment in production facilities and the
acquisition of external resources.
Taking into consideration the Company’s cash dividend payment record, as well as its dividend
payout ratio target, Lion’s Board of Directors resolved to pay an interim dividend of ¥5 per share
(payment date: September 5, 2013) and a year-end dividend of ¥5 per share (payment date: March
5, 2014) for fiscal 2013.
With regard to dividends to be paid in fiscal 2014 Lion plans to maintain both the interim and
year-end dividend at ¥5 per share each, reflecting its basic policy on the distribution of earnings and
cash dividends. As a result, the total annual dividend is expected to be ¥10 per share.
Lion Corporation (Code 4912): Consolidated Financial Statements for the Year Ended December 31, 2013
10
4. Business Risks
The Lion Group’s management performance and financial status may be adversely affected by
various risks as business activities are pursued in the future. Of these risks, the following items, in
particular, may have a material impact on the decisions of investors.
Forward-looking statements are based on decisions made by the Lion Group as of February 10,
2014.
Business risks are not limited to the items listed below.
(1) Product quality and value The Lion Group plans, develops, produces, and sells products under management based on international quality standards while strictly following related laws and regulations, such as the Pharmaceutical Affairs Law, to provide worry-free, safe, convenient, and environmentally conscious products to consumers. In addition, we use consumers’ opinions received through our Consumer Service Office to improve our products and packaging as well as respective displays and text. In the event of an unforeseen and serious problem with product quality, however, the affected product and all products made by the Lion Group may lose their perceived value. This may adversely affect the Lion Group’s management performance and financial status. (2) Changes in raw material prices The Lion Group’s products use petrochemical and vegetable oils and fats as basic materials. Since these materials are easily affected by international market prices, we have measures in place to reduce costs and diversify the range of materials used. However, an increase in raw material prices may adversely affect the Lion Group’s management performance and financial status.
(3) Exchange rate fluctuations
The Lion Group translates into yen the financial statements of overseas subsidiaries when
preparing consolidated financial statements. For items denominated in foreign currency, their yen
values may be affected by prevailing foreign exchange rates when translated into yen. The Lion
Group has taken steps to minimize the risk of an increase in raw material costs by hedging against
exchange rate fluctuations. However, short-, medium-, and long-term changes in foreign exchange
rates may adversely affect the Lion Group’s management performance and financial status.
(4) Major lawsuits As of December 31, 2013, Lion is not involved in any lawsuits that may have significant impact on its business. However, if the Lion Group were to be successfully sued for significant damages, these could adversely affect the Lion Group’s management performance and financial status. (5) Earthquakes and other natural disasters In the product manufacturing process, the Lion Group has put in place safety measures against earthquakes and other natural disasters. In the event of a major disaster, however, our production equipment may be damaged, or a suspension of raw materials procurement or distribution activities may cause business activities to cease, adversely affecting the Lion Group’s management performance and financial status.
Lion Corporation (Code 4912): Consolidated Financial Statements for the Year Ended December 31, 2013
11
II. Corporate Group
The Lion Group consists of Lion Corporation, 26 subsidiaries (including 25 consolidated subsidiaries and
one non-consolidated equity-method subsidiaries), and 13 affiliates (including seven equity-method
affiliates). Principal business activities consist of the manufacture and sale of consumer products,
industrial products and overseas. Other business activities involve distribution related to the above
business activities and other services.
The relationship between group business activities and business segments is shown below, which is
based on the categorization used for business segments.
Business segment Main activities Main companies
Consumer Products Business
Manufacture and sale of domestic commodities, OTC drugs and functional food products in Japan
PT. IPPOSHA INDONESIA CJ Lion Corporation Lion Chemical Industry (Taiwan) Co., Ltd. Lion Corporation (Thailand) Ltd. Peerless Lion Corporation Lion Service Co., Ltd. Eastern Silicate Company Limited Southern Lion Sdn. Bhd. P.T. Lion Wings
Other
Transport and storage of merchandise and finished products; design, construction, and maintenance of storage facilities; real estate management; Human resources services, etc.
Domestic affiliates
Lion Engineering Co., Ltd. Lion Cordial Support Co., Ltd. Lion Business Service Co., Ltd. Lion Logistics Service Company, Ltd. Planet Logistics Co., Ltd. Planet, Inc.
Lion Corporation (Code 4912): Summary of Financial Statements for the Year Ended December 31, 2013
12
Business Organization Chart
Sale of pet food products Sale of dental
products Sale of cosmetics and beauty equipments Manufacture and sale
of kitchen detergents Manufacture and sale of surfactants Manufacture and sale of
(Consolidated subsidiaries) Lion Packaging Co., Ltd. Lion Chemical Co., Ltd.
(Equity-method subsidiaries) Lion Akzo Co., Ltd.
Overseas customers
Note: The thick arrows represent transactions of merchandise, finished products, and raw materials. The line arrows represent provision of services, etc.
Sales promotion services
(Consolidated subsidiaries) Lion Field Marketing Co., Ltd.
Share of other comprehensive income of associates accounted for using equity method
209 169
Total other comprehensive income 6,583 6,548
Comprehensive income 11,478 13,261
Comprehensive income attributable to:
Comprehensive income attributable to owner of the parent
10,209 11,970
Comprehensive income attributable to minority interests
1,268 1,290
Lion Corporation (Code 4912): Consolidated Financial Statements for the Year Ended December 31, 2013
22
3. Consolidated Statement of Changes in Shareholders’ Equity Consolidated Results for the Year Ended December 31, 2012 (January 1 to December 31, 2012)
(Millions of yen)
Shareholders’ equity
Capital stock Capital surplus Retained earnings
Treasury stock Total shareholders' equity
Balance at the start of current period
34,433 31,499 56,755 (16,653) 106,035
Changes of items during the period
Dividends from surplus (2,954) (2,954)
Net income 4,235 4,235
Purchase of treasury stock (155) (155)
Disposal of treasury stock (40) 152 111
Net changes of items other than shareholders' equity
Total changes of items during the period
- - 1,241 (2) 1,238
Balance at the end of current period
34,433 31,499 57,996 (16,656) 107,273
(Millions of yen)
Accumulated other comprehensive income
Valuation difference on available-for-sale securities
Deferred gains or losses on hedges
Foreign currency translation adjustment
Accumulated other comprehensive income
Subscription rights to shares
Minority interests
Net assets
Balance at the start of current period
(351) (6) (3,628) (3,986) 180 3,023 105,252
Changes of items during the period
Dividends from surplus
(2,954)
Net income 4,235
Purchase of treasury stock
(155)
Disposal of treasury stock
111
Net changes of items other
than shareholders' equity
4,040 13 1,919 5,973 (50) 1,749 7,672
Total changes of items during the period
4,040 13 1,919 5,973 (50) 1,749 8,911
Balance at the end of current period
3,688 6 (1,708) 1,987 129 4,772 114,163
Lion Corporation (Code 4912): Consolidated Financial Statements for the Year Ended December 31, 2013
23
Consolidated Results for the Year Ended December 31, 2013 (January 1 to December 31, 2013)
(Millions of yen)
Shareholders’ equity
Capital stock Capital surplus Retained earnings
Treasury stock Total shareholders' equity
Balance at the start of current period
34,433 31,499 57,996 (16,656) 107,273
Changes of items during the period
Dividends from surplus (2,683) (2,683)
Net income 6,097 6,097
Purchase of treasury stock (101) (101)
Disposal of treasury stock 0 2 2
Net changes of items other than shareholders' equity
Total changes of items during the period
- 0 3,413 (99) 3,314
Balance at the end of current period
34,433 31,499 61,410 (16,755) 110,588
(Millions of yen)
Accumulated other comprehensive income
Valuation difference on available-for-sale securities
Deferred gains or losses on hedges
Foreign currency translation adjustment
Accumulated other comprehensive income
Subscription rights to shares
Minority interests
Net assets
Balance at the start of current period
3,688 6 (1,708) 1,987 129 4,772 114,163
Changes of items during the period
Dividends from surplus
(2,683)
Net income 6,097
Purchase of treasury stock
(101)
Disposal of treasury stock
2
Net changes of items other than shareholders' equity
3,232 17 2,622 5,873 63 817 6,754
Total changes of items during the period
3,232 17 2,622 5,873 63 817 10,069
Balance at the end of current period
6,921 24 914 7,860 193 5,590 124,232
Lion Corporation (Code 4912): Consolidated Financial Statements for the Year Ended December 31, 2013
24
4. Consolidated Statements of Cash Flows
(Millions of yen)
Fiscal year
Ended December 31, 2012
Fiscal year Ended December
31, 2013
Net cash provided by (used in) operating activities
Income before income taxes and minority interests 8,594 10,925
Depreciation and amortization 11,834 11,227
Impairment loss 131 1,962
Increase (decrease) in provision for bonuses (238) 156
Increase (decrease) in provision for retirement benefits (810) (378)
Interest and dividends income (672) (772)
Interest expenses 698 726
Loss (gain) on disposal of noncurrent assets (94) 858
Loss (gain) on sales of investment securities (67) (1,428)
Loss (gain) on valuation of investment securities - 40
Equity in (earnings) losses of affiliates (803) (696)
Decrease (increase) in notes and accounts receivable-trade 5,572 (4,167)
Decrease (increase) in inventories (725) (2,207)
Increase (decrease) in notes and accounts payable-trade (2,546) 8,440
Increase (decrease) in accounts payable-other and accrued expenses (724) 304
Increase (decrease) in other current liabilities 214 293
Decrease (increase) in other current assets (493) (281)
Other, net 91 (209)
Subtotal 19,961 24,793
Interest and dividends income received 1,199 1,068
Interest expenses paid (678) (711)
Income taxes paid (1,719) (2,240)
Net cash provided by (used in) operating activities 18,762 22,910
Net cash provided by (used in) investment activities
Decrease (increase) in time deposits (886) (69)
Purchases of property, plant and equipment (7,973) (14,649)
Proceeds from sales of property, plant and equipment 457 183
Purchase of intangible assets (907) (112)
Purchase of investment securities (73) (1,018)
Proceeds from sales of investment securities 110 2,802
Payments of loans receivable (0) (162)
Collection of loans receivable 8 157
Other, net 93 49
Net cash provided by (used in) investment activities (9,172) (12,819)
Lion Corporation (Code 4912): Consolidated Financial Statements for the Year Ended December 31, 2013
25
(Millions of yen)
Fiscal year
Ended December 31, 2012
Fiscal year Ended December
31, 2013
Net cash provided by (used in) financing activities
Increase in short-term loans payable 15,747 18,881
Decrease in short-term loans payable (15,441) (15,967)
Repayment of long-term loans payable (2,416) (2,416)
Purchase of treasury stock (20) (101)
Proceeds from disposal of treasury stock 3 2
Cash dividends paid (2,959) (2,676)
Cash dividend to minority shareholders (239) (440)
Proceeds from minority interests in establishment of consolidated subsidiaries
545 -
Other, net (142) (52)
Net cash provided by (used in) financing activities (4,923) (2,772)
Effect of exchange rate change on cash and cash equivalents 602 709
Net increase (decrease) in cash and cash equivalents 5,269 8,027
Cash and cash equivalents at beginning of period 35,640 40,913
Increase in cash and cash equivalents from newly consolidated subsidiary
3 -
Cash and cash equivalents at end of period 40,913 48,941
Lion Corporation (Code 4912): Consolidated Financial Statements for the Year Ended December 31, 2013
26
5. Segment Information
[Segment Information]
1. Overview of Reportable Segments
The reportable segments of Lion Corporation comprise those entities for which obtaining separate
financial reports is possible and that are subject to regular review by the Board of Directors, which
decides upon the distribution of management resources to said segments.
Lion Corporation positions segments distinguished by their products within each business division.
Each segment proposes comprehensive product strategies while pursuing business expansion.
Affiliated companies in Japan undertake business activities that are in line with the characteristics
of their respective products and services.
Affiliated companies located overseas are independent management units that conduct business
activities that conform to the characteristics of the regions in which they operate.
The three reportable segments (distinguished by products, services and regions) that therefore